Command Palette

Search for a command to run...

Clinical Trials · NCT02829502

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

UnknownPhase 2Exenatide (Unclear)
Phase
Phase 2
Recruitment status
Unknown
Sponsor
Christina Kruuse
Enrollment
30
Start date
Aug 2016
Locations
1 site, Denmark
Primary endpoint
Changes in the mean flow velocity in the middle cerebral arteries and in cortical oxigination.
View Exenatide compound reference